Non-Medicare and high-acuity care revenues proceed to develop considerably at Amedisys Inc. (Nasdaq: AMED).

As the corporate waits to change into a part of UnitedHealth Group (NYSE: UNH) – in a $3.3 billion deal – it has repeatedly reported vital positive factors in these two areas.

Within the third quarter, Amedisys' whole same-store residence care admissions elevated 12% year-over-year. The variety of admissions for intensive care grew by 51%. These essential care admissions are powered by Contessa Well being, which was acquired by Amedisys in 2021 for $250 million.

Whole web companies income within the quarter was $587.7 million, up 5.7% yr over yr.

Residence care revenues totaled $372.1 million, up 5.1% yr over yr. Conventional Medicare revenues fell by practically $6 million year-over-year, whereas non-Medicare revenues elevated by greater than $26 million.

In essential care, income grew to $7.7 million within the quarter, up 75% year-over-year from the $4.4 million introduced in in Q3 2023.
Amedisys is anticipated to change into a part of UnitedHealth Group's Optum in coming months, though the deal has come underneath scrutiny from federal and state regulators.